Variant report
Variant | nsv1029054 |
---|---|
Chromosome Location | chr8:47525564-47558092 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:151)
- CpG islands (count:306)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr8:47529231-47529761 | K562 | blood: | n/a | n/a |
2 | ATF1 | chr8:47548283-47548344 | K562 | blood: | n/a | n/a |
3 | ATF1 | chr8:47551373-47551428 | K562 | blood: | n/a | n/a |
4 | ATF3 | chr8:47529101-47529363 | K562 | blood: | n/a | n/a |
5 | BACH1 | chr8:47536608-47536724 | K562 | blood: | n/a | n/a |
6 | BHLHE40 | chr8:47528443-47529576 | K562 | blood: | n/a | chr8:47528874-47528890 chr8:47529336-47529352 |
7 | CBX3 | chr8:47529072-47529420 | K562 | blood: | n/a | n/a |
8 | CCNT2 | chr8:47528797-47529481 | K562 | blood: | n/a | n/a |
9 | CEBPB | chr8:47557988-47558287 | MCF-7 | breast: | n/a | chr8:47558092-47558103 |
10 | CEBPB | chr8:47550037-47550193 | K562 | blood: | n/a | n/a |
11 | CEBPB | chr8:47529068-47529484 | K562 | blood: | n/a | n/a |
12 | CEBPB | chr8:47557938-47558285 | IMR90 | lung: | n/a | chr8:47558092-47558103 |
13 | CEBPB | chr8:47534167-47534483 | HepG2 | liver: | n/a | n/a |
14 | CEBPB | chr8:47534198-47534462 | K562 | blood: | n/a | n/a |
15 | CEBPB | chr8:47549830-47550230 | MCF-7 | breast: | n/a | n/a |
16 | CEBPB | chr8:47557913-47558274 | K562 | blood: | n/a | chr8:47558092-47558103 |
17 | CEBPB | chr8:47534171-47534437 | A549 | lung: | n/a | n/a |
18 | CEBPB | chr8:47546537-47546824 | A549 | lung: | n/a | chr8:47546682-47546693 |
19 | CEBPB | chr8:47529169-47529350 | K562 | blood: | n/a | n/a |
20 | CEBPB | chr8:47547969-47548257 | HepG2 | liver: | n/a | n/a |
21 | CEBPB | chr8:47557908-47558267 | HepG2 | liver: | n/a | chr8:47558092-47558103 |
22 | CEBPB | chr8:47546527-47547003 | IMR90 | lung: | n/a | chr8:47546682-47546693 |
23 | CEBPB | chr8:47546616-47546808 | K562 | blood: | n/a | chr8:47546682-47546693 |
24 | CEBPB | chr8:47554881-47555207 | Hela-S3 | cervix: | n/a | n/a |
25 | CEBPB | chr8:47557878-47558315 | MCF-7 | breast: | n/a | chr8:47558092-47558103 |
26 | CEBPB | chr8:47548607-47548874 | A549 | lung: | n/a | chr8:47548763-47548774 |
27 | CEBPB | chr8:47549388-47550184 | HepG2 | liver: | n/a | n/a |
28 | CEBPB | chr8:47549465-47550234 | IMR90 | lung: | n/a | n/a |
29 | CEBPB | chr8:47557928-47558275 | A549 | lung: | n/a | chr8:47558092-47558103 |
30 | CEBPB | chr8:47529077-47529452 | K562 | blood: | n/a | n/a |
31 | CEBPB | chr8:47547945-47548304 | A549 | lung: | n/a | n/a |
32 | CEBPB | chr8:47554880-47555156 | HepG2 | liver: | n/a | n/a |
33 | CEBPB | chr8:47554606-47555182 | A549 | lung: | n/a | n/a |
34 | CEBPB | chr8:47548637-47548787 | HepG2 | liver: | n/a | chr8:47548763-47548774 |
35 | CEBPB | chr8:47540841-47541021 | HepG2 | liver: | n/a | chr8:47540937-47540948 |
36 | CEBPB | chr8:47546529-47547110 | HepG2 | liver: | n/a | chr8:47546682-47546693 |
37 | CEBPB | chr8:47554849-47555188 | MCF-7 | breast: | n/a | n/a |
38 | CEBPB | chr8:47534139-47534510 | IMR90 | lung: | n/a | n/a |
39 | CEBPB | chr8:47552473-47553612 | HepG2 | liver: | n/a | n/a |
40 | CEBPB | chr8:47529073-47529534 | MCF-7 | breast: | n/a | n/a |
41 | CEBPB | chr8:47554887-47555177 | K562 | blood: | n/a | n/a |
42 | CEBPB | chr8:47554891-47555151 | K562 | blood: | n/a | n/a |
43 | CEBPB | chr8:47525869-47526123 | K562 | blood: | n/a | n/a |
44 | CEBPB | chr8:47557998-47558160 | K562 | blood: | n/a | chr8:47558092-47558103 |
45 | CEBPB | chr8:47530129-47530132 | K562 | blood: | n/a | n/a |
46 | CEBPB | chr8:47552480-47553588 | A549 | lung: | n/a | n/a |
47 | CEBPB | chr8:47549385-47550207 | A549 | lung: | n/a | n/a |
48 | CEBPD | chr8:47530526-47530797 | K562 | blood: | n/a | n/a |
49 | CHD2 | chr8:47525880-47525892 | HepG2 | liver: | n/a | n/a |
50 | CHD2 | chr8:47528496-47528521 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:47527657-47527707 | H1-hESC | embryonic stem cell: | embryo |
2 | chr8:47527657-47527707 | H1-hESC | embryonic stem cell: | embryo |
3 | chr8:47526309-47526359 | H1-hESC | embryonic stem cell: | embryo |
4 | chr8:47526309-47526359 | HRCEpiC | kidney: | n/a |
5 | chr8:47529545-47529595 | NHBE | bronchial: | n/a |
6 | chr8:47529015-47529065 | HL-60 | blood: | n/a |
7 | chr8:47529545-47529595 | SK-N-SH_RA | brain: | n/a |
8 | chr8:47529545-47529595 | LNCaP | prostate: | n/a |
9 | chr8:47529280-47529330 | NH-A | brain: | n/a |
10 | chr8:47529545-47529595 | NHDF-neo | bronchial: | n/a |
11 | chr8:47529015-47529065 | HRPEpiC | eye: | n/a |
12 | chr8:47529015-47529065 | GM12891 | blood: | n/a |
13 | chr8:47526309-47526359 | ECC-1 | luminal epithelium: | n/a |
14 | chr8:47529545-47529595 | HepG2 | liver: | n/a |
15 | chr8:47529545-47529595 | HL-60 | blood: | n/a |
16 | chr8:47527657-47527707 | HNPCEpiC | eye: | n/a |
17 | chr8:47526309-47526359 | CMK | blood: | n/a |
18 | chr8:47526309-47526359 | HCM | heart: | n/a |
19 | chr8:47527657-47527707 | ovcar-3 | ovarian: | n/a |
20 | chr8:47529280-47529330 | NT2-D1 | testis: | n/a |
21 | chr8:47529015-47529065 | Hepatocyte | liver: | n/a |
22 | chr8:47527657-47527707 | GM12878 | blood: | n/a |
23 | chr8:47526309-47526359 | PANC-1 | pancreas: | n/a |
24 | chr8:47527657-47527707 | Hepatocyte | liver: | n/a |
25 | chr8:47529280-47529330 | NHDF-neo | bronchial: | n/a |
26 | chr8:47529015-47529065 | CMK | blood: | n/a |
27 | chr8:47529280-47529330 | AG09309 | skin: | n/a |
28 | chr8:47529545-47529595 | PrEC | prostate: | n/a |
29 | chr8:47529280-47529330 | ProgFib | skin: | n/a |
30 | chr8:47529545-47529595 | PFSK-1 | brain: | n/a |
31 | chr8:47529280-47529330 | PrEC | prostate: | n/a |
32 | chr8:47529015-47529065 | A549 | lung: | n/a |
33 | chr8:47529545-47529595 | HAEpiC | amniotic membrane: | n/a |
34 | chr8:47526309-47526359 | ProgFib | skin: | n/a |
35 | chr8:47529015-47529065 | PANC-1 | pancreas: | n/a |
36 | chr8:47529280-47529330 | HCF | heart: | n/a |
37 | chr8:47527657-47527707 | T-47D | breast: | n/a |
38 | chr8:47529015-47529065 | MCF10A-Er-Src | breast: | n/a |
39 | chr8:47526309-47526359 | AG04450 | lung: | fetal |
40 | chr8:47529280-47529330 | NHBE | bronchial: | n/a |
41 | chr8:47526309-47526359 | Caco-2 | colon: | n/a |
42 | chr8:47529545-47529595 | HPAEpiC | pulmonary alveolar: | n/a |
43 | chr8:47529015-47529065 | Hela-S3 | cervix: | n/a |
44 | chr8:47526309-47526359 | SKMC | muscle: | n/a |
45 | chr8:47529280-47529330 | PFSK-1 | brain: | n/a |
46 | chr8:47526309-47526359 | NH-A | brain: | n/a |
47 | chr8:47529280-47529330 | HUVEC | blood vessel: | n/a |
48 | chr8:47526309-47526359 | HMEC | breast: | n/a |
49 | chr8:47529545-47529595 | ProgFib | skin: | n/a |
50 | chr8:47527657-47527707 | CMK | blood: | n/a |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:47524927..47529861-chr8:47530508..47536088,6 | K562 | blood: | |
2 | chr8:47515437..47518605-chr8:47528973..47530959,3 | K562 | blood: | |
3 | chr8:47528106..47530039-chr8:47536064..47537656,2 | MCF-7 | breast: | |
4 | chr8:47528106..47530039-chr8:47536064..47537656,2 | MCF-7 | breast: | |
5 | chr8:47512649..47514644-chr8:47529072..47530746,2 | K562 | blood: | |
6 | chr7:97501587..97502366-chr8:47529051..47529557,3 | HCT-116 | colon: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ASNSP1 | TF binding region |
ASNSP1 | CpG island |
ENSG00000248498 | chromatin interactions |
ENSG00000070669 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561786945 | chr8:47525598-47525599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575385969 | chr8:47525601-47525602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543898997 | chr8:47525610-47525611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564097483 | chr8:47525620-47525621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs528414998 | chr8:47525625-47525626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs532738094 | chr8:47525629-47525630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552845393 | chr8:47525634-47525635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559763725 | chr8:47525636-47525637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs4242444 | chr8:47525643-47525644 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs548355465 | chr8:47525645-47525646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs557968856 | chr8:47525657-47525658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs74483771 | chr8:47525719-47525720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs76730218 | chr8:47525725-47525726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs114815065 | chr8:47525773-47525774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551638067 | chr8:47525802-47525803 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs79341361 | chr8:47525813-47525814 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10096410 | chr8:47525814-47525815 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146288001 | chr8:47525816-47525817 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs375737518 | chr8:47525835-47525836 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs4872665 | chr8:47525845-47525846 | Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs112427162 | chr8:47525853-47525854 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376947999 | chr8:47525860-47525861 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543677165 | chr8:47525869-47525870 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs186501664 | chr8:47525901-47525902 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs78887902 | chr8:47525912-47525913 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535674347 | chr8:47525914-47525915 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs74956660 | chr8:47525940-47525941 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs76458771 | chr8:47525951-47525952 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs11992981 | chr8:47525986-47525987 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555583467 | chr8:47526013-47526014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575449709 | chr8:47526022-47526023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs113153303 | chr8:47526030-47526031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs190956590 | chr8:47526056-47526057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369117345 | chr8:47526059-47526060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574042582 | chr8:47526126-47526127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563976965 | chr8:47526131-47526132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372687974 | chr8:47526132-47526133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs138720458 | chr8:47526151-47526152 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs200013649 | chr8:47526172-47526173 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs6558273 | chr8:47526205-47526206 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs528630067 | chr8:47526211-47526212 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs143902051 | chr8:47526215-47526216 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs548415319 | chr8:47526233-47526234 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs113325714 | chr8:47526238-47526239 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs561943422 | chr8:47526282-47526283 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs530962941 | chr8:47526309-47526310 | Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs551064835 | chr8:47526319-47526320 | Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs149361716 | chr8:47526395-47526396 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs539841531 | chr8:47526454-47526455 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs530701374 | chr8:47526470-47526471 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Oral cancer | 21386901 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 20409316 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:47520200-47525800 | Weak transcription | K562 | blood |
2 | chr8:47525800-47526000 | Genic enhancers | K562 | blood |
3 | chr8:47526000-47526200 | Enhancers | K562 | blood |
4 | chr8:47526200-47527000 | Weak transcription | K562 | blood |
5 | chr8:47527000-47529400 | Active TSS | K562 | blood |
6 | chr8:47528200-47529200 | Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr8:47528200-47529200 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr8:47528600-47528800 | Bivalent/Poised TSS | Skeletal Muscle Male | skeletal muscle |
9 | chr8:47528600-47529400 | Active TSS | Pancreas | Pancrea |
10 | chr8:47528800-47529200 | ZNF genes & repeats | Placenta | Placenta |
11 | chr8:47529000-47529200 | Bivalent/Poised TSS | ES-I3 Cell Line | embryonic stem cell |
12 | chr8:47529200-47529600 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
13 | chr8:47529400-47529800 | Flanking Active TSS | K562 | blood |
14 | chr8:47529400-47531400 | Weak transcription | Pancreas | Pancrea |
15 | chr8:47529800-47531000 | Enhancers | K562 | blood |
16 | chr8:47531600-47535200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr8:47531800-47532200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
18 | chr8:47534800-47535200 | Enhancers | Skeletal Muscle Male | skeletal muscle |
19 | chr8:47539400-47539800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr8:47547400-47549400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
21 | chr8:47547400-47549600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
22 | chr8:47548000-47549200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
23 | chr8:47549400-47554800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
24 | chr8:47549600-47555000 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
25 | chr8:47554800-47555600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
26 | chr8:47555000-47556600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
27 | chr8:47555600-47560600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
28 | chr8:47556600-47560600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |